Totals
- Total revenue
- $14,845,158
- Total expenses
- $13,471,121
- Contributions and grants received
- $3,847,538
- Grants paid
- $0
- Program service revenue
- $10,596,770
- Investment income
- $395,850
- Other revenue
- $5,000
- Total assets, end of year
- $22,281,077
- Total liabilities, end of year
- $10,464,726
- Net assets or fund balances, end of year
- $11,816,351
- Program services expenses (Part IX)
- $12,731,598
- Management and general expenses
- $739,523
- Fundraising expenses
- $0
- Program service expenses (Part III)
- $12,731,598
Program services were 94.5% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1e · Government grants (contributions)
$3,826,038
-
1f · All other contributions, gifts and grants
$21,500
-
2a · Program service revenue: INDUSTRY REVENUE
total $10,596,770 · related or exempt $10,596,770
-
3 · Investment income
total $401,639 · excluded $401,639
-
7a · Gross sales of assets other than inventory
securities $1,645,882
-
7b · Less cost or other basis and sales expenses
securities $1,651,671
-
7c · Gain or loss
securities -$5,789
-
7d · Net gain or loss
total -$5,789 · excluded -$5,789
-
11a · Other revenue: MISCELLANEOUS
total $5,000 · related or exempt $5,000
-
11e · Other revenue, total
$5,000
Functional expenses
Part IX, the statement of functional expenses.
-
11b · Fees: legal
total $9,885 · management and general $9,885
-
11c · Fees: accounting
total $366,283 · program services $2,800 · management and general $363,483
-
11g · Fees: other
total $2,246,602 · program services $2,185,602 · management and general $61,000
-
19 · Conferences, conventions and meetings
total $2,488 · management and general $2,488
-
23 · Insurance
total $8,206 · management and general $8,206
-
24a · Other expenses: SUB-AWARD RESEARCH PROJ
total $8,126,667 · program services $7,864,987 · management and general $261,680
-
24b · Other expenses: SITE EXPENSES
total $2,676,419 · program services $2,676,419
-
24c · Other expenses: MISCELLANEOUS
total $33,876 · program services $1,188 · management and general $32,688
-
24d · Other expenses: POSTAGE & SHIPPING
total $695 · program services $602 · management and general $93
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $8,232,069 · end of year $4,140,951
-
2 · Savings and temporary cash investments
beginning of year $3,702,103 · end of year $6,489,326
-
4 · Accounts receivable
beginning of year $5,097,505 · end of year $5,414,792
-
9 · Prepaid expenses and deferred charges
beginning of year $15,281
-
11 · Investments: publicly traded securities
beginning of year $2,390,687 · end of year $5,374,671
-
15 · Other assets
beginning of year $889,600 · end of year $861,337
-
17 · Accounts payable and accrued expenses
beginning of year $2,342,111 · end of year $3,420,641
-
19 · Deferred revenue
beginning of year $7,908,273 · end of year $7,044,085
-
27 · Net assets without donor restrictions
beginning of year $10,076,861 · end of year $11,816,351
Mission and programs · 2025
Mission
THE MISSION OF RTOG FOUNDATION, INC. (RTOGF) IS TO:(1) IMPROVE THE SURVIVAL OUTCOME AND QUALITY OF LIFE OF ADULTS WITH CANCER THROUGH THE CONDUCT OF HIGH-QUALITY CLINICAL TRIALS, (2) EVALUATE NEW FORMS OF RADIOTHERAPY DELIVERY AND TEST NEW SYSTEMIC AND TARGETED THERAPIES IN CONJUNCTION WITH RADIOTHERAPY IN THE CONTEXT OF CLINICAL RESEARCH, (3) PARTICIPATE AS ONE OF THREE MEMBER ORGANIZATIONS IN THE ACTIVITIES OF NRG ONCOLOGY FOUNDATION, (4) DEVELOP AND CONDUCT PRACTICE-CHANGING CLINICAL TRIALS FOR THE NCI NATIONAL CLINICAL TRIAL NETWORK (NCTN) THROUGH RTOGF'S MEMBERSHIP IN NRG ONCOLOGY, (5) DEVELOP AND CONDUCT INDUSTRY-SUPPORTED CLINICAL TRIALS THAT ARE IMPORTANT TO RTOGF'S RESEARCH MISSION, (6) PROVIDE FUNDING FOR BASIC, CLINICAL, AND TRANSLATIONAL INVESTIGATORS TO COLLABORATE WITH RTOGF IN THE DEVELOPMENT OF BOTH BIOLOGIC AND BIOPHYSICAL TARGETED THERAPIES, AND (7) SUPPORT YOUNG INVESTIGATORS FROM MANY DISCIPLINES WITHIN THE RTOGF RESEARCH ENTERPRISE.
Activities or mission (Part I)
TO ORGANIZE & PROVIDE FUNDING FOR MULTI-CENTER CLINICAL RESEARCH ACTIVITIES IN ONCOLOGY.
-
RTOGF'S PRIMARY PROGRAM CONSTITUTES THE FOLLOWING: (1) IMPROVE THE SURVIVAL OUTCOME AND QUALITY OF LIFE OF ADULTS WITH CANCER THROUGH THE CONDUCT OF HIGH-QUALITY CLINICAL TRIALS, (2) EVALUATE NEW FORMS OF RADIOTHERAPY DELIVERY AND TEST NEW SYSTEMIC AND TARGETED THERAPIES IN CONJUNCTION WITH RADIOTHERAPY IN THE CONTEXT OF CLINICAL RESEARCH, (3) PARTICIPATE AS ONE OF THREE MEMBER ORGANIZATIONS IN THE ACTIVITIES OF NRG ONCOLOGY FOUNDATION, (4) DEVELOP AND CONDUCT PRACTICE-CHANGING CLINICAL TRIALS FOR THE NCI NATIONAL CLINICAL TRIAL NETWORK (NCTN) THROUGH RTOGF'S MEMBERSHIP IN NRG ONCOLOGY, (5) DEVELOP AND CONDUCT INDUSTRY-SUPPORTED CLINICAL TRIALS THAT ARE IMPORTANT TO RTOGF'S RESEARCH MISSION, (6) PROVIDE FUNDING FOR BASIC, CLINICAL, AND TRANSLATIONAL INVESTIGATORS TO COLLABORATE WITH RTOGF IN THE DEVELOPMENT OF BOTH BIOLOGIC AND BIOPHYSICAL TARGETED THERAPIES, AND (7) SUPPORT YOUNG INVESTIGATORS FROM MANY DISCIPLINES WITHIN THE RTOGF RESEARCH ENTERPRISE.
Expenses $12,731,598 · Revenue $10,601,770
As filed on the 2025 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Dow WilsonDOW WILSON
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Graham Burnette EsqGRAHAM BURNETTE ESQ
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Jeff Michalski MD MBAJEFF MICHALSKI MD MBA
TREASURER
- Total calculated
- $0
- Hours/week
- 1
-
Jim Dignam PhDJIM DIGNAM PHD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Kristin Higgins MDKRISTIN HIGGINS MD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Lisa Kachnic MDLISA KACHNIC MD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Mitchell Machtay MDMITCHELL MACHTAY MD
PRESIDENT & CEO
- Total calculated
- $0
- Hours/week
- 5
-
Quynh-Thu Le MDQUYNH-THU LE MD
CHAIR
- Total calculated
- $0
- Hours/week
- 5
-
Seth Rosenthal MDSETH ROSENTHAL MD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Stuart Wong MDSTUART WONG MD
SECRETARY
- Total calculated
- $0
- Hours/week
- 1
-
Sue Yom MDSUE YOM MD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Walter J Curran Jr MDWALTER J CURRAN JR MD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Mark Mishra MDMARK MISHRA MD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Edwin Posadas MDEDWIN POSADAS MD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.
Grants on this return
No itemized grants to organizations on this return.
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
501(C)(3) · ONCOLOGY RESEARCH SUPPORT · PA
Provenance
- Return type
- form_990
- Tax year
- 2025
- Filed
- 24 September 2026
- IRS schema version
- 2025v4.2
- Source object
- 202602679349301415
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.